M
Mitsugu Kochi
Researcher at Nihon University
Publications - 90
Citations - 1072
Mitsugu Kochi is an academic researcher from Nihon University. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 16, co-authored 76 publications receiving 842 citations.
Papers
More filters
Journal ArticleDOI
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial
Kazuhiro Yoshida,Yasuhiro Kodera,Mitsugu Kochi,Wataru Ichikawa,Yoshihiro Kakeji,Takeshi Sano,Narutoshi Nagao,Masazumi Takahashi,Akinori Takagane,Takuya Watanabe,Masahide Kaji,Hiroshi Okitsu,Takashi Nomura,Takanori Matsui,Takaki Yoshikawa,Jin Matsuyama,Makoto Yamada,Seiji Ito,Masahiro Takeuchi,Masashi Fujii +19 more
TL;DR: Addition of docetaxel to S-1 is effective with few safety concerns in patients with stage III gastric cancer, and the present findings may also be applicable in countries in which perioperative adjuvant chemotherapy or chemoradiation is not standard.
Journal ArticleDOI
Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer.
Mitsugu Kochi,Masashi Fujii,Noriaki Kanamori,Teruo Kaiga,Tetsuya Kawakami,Kazuo Aizaki,Mitsuko Kasahara,Fumiro Mochizuki,Yuichi Kasakura,Motoo Yamagata +9 more
TL;DR: Serum CEA level is an independent prognostic factor in patients with primary gastric cancer and is a useful indicator of curability in patients who undergo gastrectomy.
Journal ArticleDOI
Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer
TL;DR: The spleen should be resected when a patient has clearly positive node metastasis around the splenic hilus and artery, and pancreaticosplenectomy be performed when the cancer lesion invades the pancreas.
Journal ArticleDOI
Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial.
Shigeoki Hayashi,Tadatoshi Takayama,Hideki Masuda,Mitsugu Kochi,Yukimoto Ishii,Minoru Matsuda,Motoo Yamagata,Masashi Fujii +7 more
TL;DR: The use of Seprafilm does not significantly reduce the incidence of small bowel obstruction in patients undergoing gastrectomy for gastric cancer and does not adversely affect bowel, liver, or renal functions.
Journal ArticleDOI
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials
Yu Sunakawa,Wataru Ichikawa,Akihito Tsuji,Tadamichi Denda,Yoshihiko Segawa,Yuji Negoro,Ken Shimada,Mitsugu Kochi,Masato Nakamura,Masahito Kotaka,Hiroaki Tanioka,Akinori Takagane,Satoshi Tani,Tatsuro Yamaguchi,Takanori Watanabe,Masahiro Takeuchi,Masashi Fujii,Toshifusa Nakajima +17 more
TL;DR: Primary tumor location might be a predictor of survival independent of BRAF status in mCRC patients who receive first‐line cetuximab combined with oxaliplatin‐based chemotherapy.